Everyone is watching Big Tech, but a quiet Italian pharma player is pushing into rare diseases and US markets. Is…
Read More
EU court dismisses pharma call to annul disputed wastewater rules
Ruling leaves “important legal questions regarding the validity of the Directive unresolved”, according to indusattempt association EFPIA. Since its implementation…
Read More
EU-India trade deal: Opportunity for India’s pharma sector | Lucknow News
The EU-India Free Trade Agreement, concluded recently after nearly two decades of nereceivediation, holds the promise of reshaping global pharmaceutical…
Read More
Why pharma manufacturers are still investing in Europe
Tariffs and regulations of pharmaceutical manufacturing, far from deterring investment, are enticing foreign and domestic CMDOs to establish production on…
Read More
IGC Pharma raises $234K in direct offering to fund IGC-AD1
IGC Pharma (NYSE American: IGC) announced a registered direct offering of 779,997 shares at $0.30 per share,…
Read More
HRV Pharma set to redefine India’s bulk drug business with innovative business model
Hyderabad based HRV Pharma, India’s ‘first virtual pharmaceutical company’, started off as a B2B match buildr between Indian API manufacturers…
Read More
Is NATCO Pharma (NSE:NATCOPHARM) A Risky Investment?
The external fund manager backed by Berkshire Hathaway’s Charlie Munger, Li Lu, creates no bones about it when he states…
Read More
EU inches closer to new pharma legislation amid competitiveness drive
Big pharma has continually called for rapid policy modify in Europe to maintain the flow of capital into the continent.…
Read More
Europe’s pharma policy shakeup relocates forward toward enactment
Andrew Joseph covers health, medicine, and the biopharma indusattempt in Europe. You can reach Andrew on Signal at drewqjoseph.45. LONDON…
Read More
In bid to improve outcomes for children with genetic bone disease, Swedish startup BOOST Pharma raises additional €3.1 million
Stockholm-based BOOST Pharma, a clinical-stage biopharmaceutical company focapplyd on developing novel cell therapies for rare skeletal pediatric diseases, today announced…
Read More
